InvestorsHub Logo
Followers 1608
Posts 120638
Boards Moderated 3
Alias Born 07/09/2003

Re: None

Friday, 03/26/2004 3:39:53 PM

Friday, March 26, 2004 3:39:53 PM

Post# of 275592
~MLHP .24 X .27 I suggest you read this recent filing over the weekend or even now.This is just an excerpt.......


Estimates of expenditures on treatment for the control and prevention of malaria are in excess of US$10 Billion annually. The World Bank, per its figures, allocates US$ 2.5 Billion to third world countries for malaria treatment.

DISTRIBUTION AND PRICING

Millenia's objective is to see that MMH MALAREX(TM) is made available to as many people, as quickly as possible. In order to accomplish this goal, Millenia will initially rely upon already existing distribution networks. Through a realistic pricing strategy, Millenia intends to make MMH MALAREX(TM) available at prices that are, for a new anti-malarial agent with no parasitic resistance, competitive with the cost of other comparable drugs currently used in the treatment of malaria. This will facilitate MMH MALAREX(TM)'S entry into the marketplace. Even within this pricing structure, the Company will generate earnings that will allow for future growth and a substantial return on our stakeholders' investment.

Millenia is currently poised to begin selling MMH MALAREX(TM) in significant quantities. To this end, it is in the final stages of negotiations with several countries to sell MMH MALAREX(TM) to them.






http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001169232%2D04%2D001800%2Etxt&FilePath....


This company could be in the dollars quite fast if they start signing contracts.It appears to me, thats whats about to happen IMO.

Your Own DD A must!
~Rig






Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.